TGFB1 and systemic lupus erythematosus: On the other hand, NETosis in systemic lupus erythematosus (SLE), inhibition of TGF-β1 signaling, IL-1 signaling, transcription androgen receptor nuclear signaling, and inhibition of RUNX3 signaling were the main enriched pathways in Th2-enriched CD4+ T cells from peripheral blood in AR patients (Fig. 2B).